UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 15, 2007 (October 15, 2007)
LUMINEX CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware | 000-30109 | 74-2747608 | ||
(State or Other Jurisdiction of Incorporation) | (Commission File | (IRS Employer | ||
Number) | Identification No.) |
12212 Technology Boulevard, Austin, Texas | 78727 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (512) 219-8020
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On October 15, 2007, Luminex Corporation issued a press release announcing the receipt of payment in connection with the settlement of the litigation with Rules Based Medicine, Inc. A copy of the press release is attached hereto asExhibit 99.1, which is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit 99.1 Press Release issued by Luminex Corporation dated October 15, 2007.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LUMINEX CORPORATION | ||||
Date: October 15, 2007 | By: | /s/ Harriss T. Currie | ||
Harriss T. Currie | ||||
Vice President, Finance Chief Financial Officer |
EXHIBIT INDEX
No. | Exhibit | |||
99.1 | Press Release issued by Luminex Corporation dated October 15, 2007. |